CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in CollPlant Biotechnologies Ltd as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +6 vs. Q3 2021
- Shares held
- 1.80M
- −157.4K (−8.0%) vs. Q3 2021
- Total value
- $29.5M
- −$3.62M (−10.9%) vs. Q3 2021
- New holders
- 10
- 4 more added
- Sold out
- 4
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 100 | $1.00K | 0.00% | +100 | New |
| Advisor Group Holdings, Inc. | 248 | $4.00K | 0.00% | +248 | New |
| Morgan Stanley | 721 | $12.0K | 0.00% | +671+1,342.0% | Added |
| Simplex Trading, LLC | 1,606 | $26.0K | 0.00% | +1,606 | New |
| FNY Investment Advisers, LLC | 2,000 | $32.0K | 0.02% | −2,000−50.0% | Reduced |
| The PNC Financial Services Group, Inc. | 3,600 | $58.0K | 0.00% | +3,600 | New |
| UBS Group AG | 5,266 | $86.0K | 0.00% | +5,266 | New |
| Susquehanna International Group, LLP | 10,578 | $173.0K | 0.00% | +10,578 | New |
| Sigma Planning Corp | 13,070 | $214.0K | 0.01% | −5,565−29.9% | Reduced |
| HRT Financial LP | 13,531 | $221.0K | 0.00% | +13,531 | New |
| LPL Financial LLC | 14,770 | $242.0K | 0.00% | +14,770 | New |
| Kingsview Wealth Management, LLC | 18,415 | $301.0K | 0.01% | +18,415 | New |
| Parallel Advisors, LLC | 20,066 | $328.0K | 0.01% | −1,228−5.8% | Reduced |
| Weil Company, Inc. | 21,210 | $347.0K | 0.16% | −3,348−13.6% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 24,623 | $403.0K | 0.00% | +24,623 | New |
| Benjamin F. Edwards & Company, Inc. | 58,694 | $960.0K | 0.04% | +1,050+1.8% | Added |
| Brown Advisory Inc | 61,350 | $1.00M | 0.00% | −100−0.2% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 165,454 | $2.71M | 0.01% | −25,836−13.5% | Reduced |
| Villere St Denis J & Co LLC | 256,872 | $4.20M | 0.24% | +8,722+3.5% | Added |
| Roumell Asset Management, LLC | 495,684 | $8.11M | 10.81% | −67,346−12.0% | Reduced |
| Investment Management of Virginia LLC | 615,554 | $10.1M | 1.62% | +44,653+7.8% | Added |
| State Street Corp | 0 | $0 | 0.00% | −182,266−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,001−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −86−100.0% | Sold out |